Company / Interest Expense per Share
Biogen Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.85
FY2025
5-year range
$1.46 / $1.85
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#5 of 41
Health Care
What the data says
Biogen's interest expense per share of $1.85 is higher than 88% of companies in the Health Care sector (FY2025). Interest Expense per Share has increased for 6 consecutive years, from $0.89 in FY2019 to $1.85 in FY2025.
Based on SEC 10-K filings.
1.85 in FY2025 with a 5-year CAGR of +10.3%. Top quartile in the Health Care sector.
Increased from $1.68 to $1.85 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
-82.1% below sector average
Key checks
Key Insights
- Biogen's interest expense per share has grown for 6 consecutive years.
- In FY2025, interest expense per share increased 6.2% year-over-year.
- Ranks #5 out of 41 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.85 | +6.2% |
| FY2024 | $1.74 | +3.5% |
| FY2023 | $1.68 | +3.8% |
| FY2022 | $1.62 | +11.1% |
| FY2021 | $1.46 | +29.0% |
| FY2020 | $1.13 | +27.3% |
| FY2019 | $0.89 | -4.6% |
| FY2018 | $0.93 | -20.0% |
| FY2017 | $1.16 | -2.3% |
| FY2016 | $1.19 | +192.2% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026